News
News Center
New trends, new opportunities — Join us and let your dreams take flight together!
2020-02-03
As stem cell technology continues to advance, transforming from fundamental research into clinical applications, the immense potential of stem cells has captured the nation's attention—so much so that countries around the world are now elevating stem cell research and its applications to the level of national strategic priorities. In 2019, cell therapy was officially included for the first time in China’s Guidance Catalog for Industrial Structure Adjustment, marking it as a key "market indicator" that will accelerate the transition of cell-based treatments from laboratory settings to broader commercialization. Stem cells are poised to become yet another powerful tool in the fight against disease.
Jiuzhitang Maker has mastered the core technologies for scaling, standardizing, and ensuring traceability in stem cell production—thanks to the introduction of Stemedica’s globally leading, clinical-grade stem cell preparation process. Through continuous innovation and growth, Jiuzhitang Maker now boasts a seasoned technical team, cutting-edge biotech support, and a robust market-advancement system. Backed by Stemedica’s advanced technological expertise from the U.S. and underpinned by a comprehensive, safety-focused, and fully standardized operational framework, Jiuzhitang Maker remains steadfast amid rapid industry transformations and fierce market competition—poised to lead with confidence into the future.
The Jiuzhitang-ALTACO International Medical Center, jointly established by Jiuzhitang and Kazakhstan’s ALACO Company at the China-Kazakhstan Khorgos International Border Cooperation Center, is an innovative collaboration platform built in response to the Belt and Road Initiative, dedicated to international stem cell research and clinical translation. The center offers clinical studies utilizing ischemia-tolerant mesenchymal stem cells produced by Stemedica, bringing new hope for recovery to patients suffering from diseases currently lacking effective treatment options.
Facing the vast blue ocean market of stem cells, our company is now actively seeking strong regional agents across the country—partners who share our vision and can help us attract top-tier resources and expertise to jointly advance the thriving field of stem cell health! We are confident that with Jiuzhitang Maker and its agents working hand in hand, we’ll successfully launch the brand into the heart of the domestic market, significantly boosting both the visibility and reach of our stem cell brand. Together, we’ll reshape the industry landscape, bringing new hope and life-saving solutions to patients who currently lack effective treatment options.
Related News
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy